Podcast
#56: Every minute matters: The power of high-sensitivity troponin
Duration: 20 Minutes
Feb 18, 2026
Our latest episode of QuidelOrtho Science Bytes features Dr. Lindy Carlstrom, Global Medical Affairs Manager for Acute Care, unpacking how high-sensitivity troponin is reshaping early cardiac diagnosis, where seconds matter most.
From detecting heart injury earlier and reducing emergency department bottlenecks to improving equity in cardiac care with sex-specific cutoffs, this episode highlights how precision diagnostics are accelerating decision-making and improving patient outcomes. Dr. Carlstrom explains the power of serial testing, the importance of assay precision and why today’s emergency teams rely on high-sensitivity troponin to confidently rule in, or rule out, acute coronary events.
High sensitivity troponin is more than a test, it’s a critical link in a faster, safer, more informed cardiac care pathway. Tune in to learn how this powerful tool is helping clinicians deliver timely insight when it matters most.
Disclaimers:
This educational podcast activity is brought to you by QuidelOrtho Corporation., and is not certified for continuing medical education. QuidelOrtho Corporation sponsors the program, and the speaker must present information following applicable FDA requirements.
About our Speaker:
About our Speaker:
Dr. Lindy Carlstrom
Global Medical Affairs Manager for QuidelOrtho.
Lindy's clinical experience spans from emergency medicine to critical care and primary care. Currently, she's responsible for providing medical support for the QuidelOrtho acute care menu throughout the product life cycle. Lindy is passionate about clinical education, testing guideline updates and assay utilization to drive improved patient-centered outcomes.
Lindy's clinical experience spans from emergency medicine to critical care and primary care. Currently, she's responsible for providing medical support for the QuidelOrtho acute care menu throughout the product life cycle. Lindy is passionate about clinical education, testing guideline updates and assay utilization to drive improved patient-centered outcomes.
Key Takeaways:
- Earlier detection, faster care: High-sensitivity troponin identifies cardiac injury sooner, supporting rapid triage and shorter Emergency Department stays
- Precision that drives confidence: Tight reproducibility ensures meaningful changes between samples reflect real patient status, not assay noise
- Accelerated rule-out pathways: Shorter 0/1 or 0/2 hour protocols help safely discharge low-risk patients sooner
- More equitable diagnosis: Sex specific cutoffs support more accurate assessment across diverse patient populations
